These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24616896)

  • 21. Severe left ventricular hypertrophy 1 year after transplant predicts mortality in cardiac transplant recipients.
    Goodroe R; Bonnema DD; Lunsford S; Anderson P; Ryan-Baille B; Uber W; Ikonomidis J; Crumbley AJ; VanBakel A; Zile MR; Pereira N
    J Heart Lung Transplant; 2007 Feb; 26(2):145-51. PubMed ID: 17258148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients.
    Chen H; Watnick T; Hong SN; Daly B; Li Y; Seliger SL
    BMC Nephrol; 2019 Oct; 20(1):386. PubMed ID: 31653199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of left ventricular hypertrophy and carotid thickening in a large selected hypertensive population: impact of different echocardiographic and ultrasonographic diagnostic criteria.
    Cuspidi C; Lonati L; Macca G; Sampieri L; Fusi V; Michev I; Severgnini B; Salerno M; Magrini F; Zanchetti A
    Blood Press; 2001; 10(3):142-9. PubMed ID: 11688761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with cardiovascular target organ damage in children after renal transplantation.
    Borchert-Mörlins B; Thurn D; Schmidt BMW; Büscher AK; Oh J; Kier T; Bauer E; Baig S; Kanzelmeyer N; Kemper MJ; Büscher R; Melk A
    Pediatr Nephrol; 2017 Nov; 32(11):2143-2154. PubMed ID: 28804814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors.
    Mitsnefes MM; Daniels SR; Schwartz SM; Meyer RA; Khoury P; Strife CF
    Pediatr Nephrol; 2000 Sep; 14(10-11):898-902. PubMed ID: 10975295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients.
    Moon KH; Song IS; Yang WS; Shin YT; Kim SB; Song JK; Park JS
    Am J Nephrol; 2000; 20(5):396-401. PubMed ID: 11092998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Echocardiographic changes and risk factors for left ventricular hypertrophy in children and adolescents after renal transplantation.
    El-Husseini AA; Sheashaa HA; Hassan NA; El-Demerdash FM; Sobh MA; Ghoneim MA
    Pediatr Transplant; 2004 Jun; 8(3):249-54. PubMed ID: 15176962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa.
    Oguntola SO; Hassan MO; Duarte R; Vachiat A; Manga P; Naicker S
    BMC Nephrol; 2019 Oct; 20(1):399. PubMed ID: 31666030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left ventricular hypertrophy in renal transplant recipients in the first year after transplantation.
    Slubowska K; Lichodziejewska B; Pruszczyk P; Szmidt J; Durlik M
    Transplant Proc; 2014 Oct; 46(8):2719-23. PubMed ID: 25380902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients.
    Tian JP; Wang T; Wang H; Cheng LT; Tian XK; Lindholm B; Axelsson J; Du FH
    Ren Fail; 2008; 30(4):391-400. PubMed ID: 18569912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants.
    Zhao X; Zhu L; Jin W; Yang B; Wang Y; Ni M; Zhao Y; Gan L; Zuo L
    BMC Cardiovasc Disord; 2022 Feb; 22(1):55. PubMed ID: 35172749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subclinical left ventricular echocardiographic abnormalities 1 year after kidney transplantation are associated with graft function and future cardiovascular events.
    Arnol M; Knap B; Oblak M; Buturović-Ponikvar J; Bren AF; Kandus A
    Transplant Proc; 2010 Dec; 42(10):4064-8. PubMed ID: 21168628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indexation criteria of ventricular mass and predictive role of blood pressure and body composition.
    Ferrara LA; Vaccaro O; Cardoni O; Laurenzi M; Mancini M; Zanchetti A
    Am J Hypertens; 2005 Oct; 18(10):1282-7. PubMed ID: 16202849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consistency of left ventricular hypertrophy diagnosed by electrocardiography and echocardiography: the Northern Shanghai Study.
    Zhang W; Zhou Y; Bai B; Yu S; Xiong J; Chi C; Teliewubai J; Li J; Blacher J; Zhang Y; Xu Y
    Clin Interv Aging; 2019; 14():549-556. PubMed ID: 30880935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7).
    Cuspidi C; Giudici V; Negri F; Meani S; Sala C; Zanchetti A; Mancia G
    J Hypertens; 2009 Dec; 27(12):2465-71. PubMed ID: 19898252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship Between SCUBE1 Levels and Echocardiography and Electrocardiography Findings and Epicardial Adipose Tissue/Carotid Intima-Media Thickness in Patients Receiving Renal Replacement Therapy.
    Ayan H; Akilli R; Kaya B; Paydas S; Kara E; Cureoglu A
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):181-187. PubMed ID: 30777551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of location and patency of the arteriovenous fistula on quality of life of kidney transplant recipients.
    Letachowicz K; Bardowska K; Królicki T; Kamińska D; Banasik M; Zajdel K; Mazanowska O; Madziarska K; Janczak D; Krajewska M
    Ren Fail; 2021 Dec; 43(1):113-122. PubMed ID: 33397180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in mediators of left ventricular hypertrophy in dialysis patients.
    Savage T; Giles M; Tomson CV; Raine AE
    Clin Nephrol; 1998 Feb; 49(2):107-12. PubMed ID: 9524781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect and correlation of patent vascular access flow on left ventricular hypertrophy in kidney transplant patients.
    Lukkanalikitkul E; Pussadhamma B; Ahooja A; Ungprasert P; Toparkngam P; Nawapun S; Takong W; Toimamueang U; Anutrakulchai S
    Int J Cardiol Heart Vasc; 2022 Jun; 40():101048. PubMed ID: 35586170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients.
    De Lima JJ; Vieira ML; Viviani LF; Medeiros CJ; Ianhez LE; Kopel L; de Andrade JL; Krieger EM; Lage SG
    Nephrol Dial Transplant; 2002 Apr; 17(4):645-51. PubMed ID: 11917059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.